+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Enzalutamide"

Prostate Cancer: Update Bulletin - Product Thumbnail Image

Prostate Cancer: Update Bulletin

  • Newsletter
  • April 2024
  • Global
From
Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
From
From
From
From
From
Castrate Resistant Prostate Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Castrate Resistant Prostate Cancer - Pipeline Insight, 2020

  • Clinical Trials
  • November 2020
  • 40 Pages
  • Global
From
From
Drug Overview: apalutamide - Product Thumbnail Image

Drug Overview: apalutamide

  • Drug Pipelines
  • January 2018
  • 18 Pages
  • Global
From
Drug Overview: darolutamide - Product Thumbnail Image

Drug Overview: darolutamide

  • Drug Pipelines
  • January 2018
  • 17 Pages
  • Global
From
Disease Analysis: Prostate Cancer - Product Thumbnail Image

Disease Analysis: Prostate Cancer

  • Report
  • March 2021
  • 94 Pages
  • Global
Drug Overview: Xtandi - Product Thumbnail Image

Drug Overview: Xtandi

  • Drug Pipelines
  • January 2018
  • 19 Pages
  • Global
From
From
Loading Indicator

Enzalutamide is a drug used to treat prostate cancer. It is a type of androgen receptor inhibitor, which works by blocking the action of male hormones that can cause the growth of prostate cancer cells. Enzalutamide is used in combination with other treatments, such as hormone therapy, chemotherapy, and radiation therapy. It is typically prescribed to men with advanced prostate cancer that has spread to other parts of the body. Enzalutamide can help slow the progression of the disease and improve quality of life. Enzalutamide is available in both oral and injectable forms. It is generally well-tolerated, with the most common side effects being fatigue, hot flashes, and joint pain. It is important to note that Enzalutamide can cause serious side effects, including seizures, liver damage, and an increased risk of stroke. Several companies are involved in the Enzalutamide market, including Astellas Pharma, Pfizer, and AstraZeneca. These companies manufacture and distribute the drug, as well as provide support services for patients. Show Less Read more